Eisai Wins Injunction In Aricept Case
Judge Harold A. Ackerman of the U.S. District Court for the District of New Jersey said in an order Friday that Eisai's patent for the drug was enforceable and that the company will likely succeed with its litigation against Teva.
“We were pleased by the ruling and the court's recognition that Teva has infringed on Eisai's...
Already a subscriber? Click here to login